| Andrea Hale Stucker, PA-C | |
|
875 Pennsylvania Ave, Bardstown, KY 40004-2529 | |
| (502) 348-5685 | |
| (502) 348-1771 |
| Full Name | Andrea Hale Stucker |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 12 Years |
| Location | 875 Pennsylvania Ave, Bardstown, Kentucky |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578821393 | NPI | - | NPPES |
| 7100212110 | Medicaid | KY | |
| PA1721 | Other | KY | MEDICAL LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | PA1721 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hardin Memorial Hospital | Elizabethtown, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kentucky Orthopedic Rehabilitation Llc | 0345157293 | 683 |
| Baptist Health Medical Group Inc | 5597867184 | 1912 |
| Kentuckyone Health Medical Group Inc | 8820993702 | 227 |
News Archive
Gilead Sciences, Inc. today announced that DAR-312 (DORADO-AC), a Phase III clinical trial evaluating darusentan, the company's endothelin receptor antagonist (ERA) for the treatment of resistant hypertension, did not achieve its co-primary efficacy endpoints of change from baseline to week 14 in trough sitting systolic blood pressure (SBP) and diastolic blood pressure (DBP) compared to placebo.
ArQule, Inc. and Daiichi Sankyo Co., Ltd. today announced the expansion of their research, development and license agreement for the discovery of novel kinase inhibitors in the field of oncology. This expanded agreement establishes a third therapeutic target, with an option for a fourth, in the field of oncology, and it includes a two-year extension based on the application of the proprietary ArQule Kinase Inhibitor Platform (AKIP™) technology.
Regenerative medicine using human pluripotent stem cells to grow transplantable tissue outside the body carries the promise to treat a range of intractable disorders, such as diabetes and Parkinson's disease.
The public has made significantly more enquiries to a national Quitline for smokers, and demand for nicotine replacement treatment vouchers has increased, following a total ban on smoking in indoor public places in New Zealand, according to a letter in this week's British Medical Journal.
Older adults living in public senior housing communities experience a large degree of loneliness, finds a new study from the Brown School at Washington University in St. Louis.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Andrea Hale Stucker, PA-C Po Box 936, London, KY 40743-0936 Ph: (606) 330-7835 | Andrea Hale Stucker, PA-C 875 Pennsylvania Ave, Bardstown, KY 40004-2529 Ph: (502) 348-5685 |
News Archive
Gilead Sciences, Inc. today announced that DAR-312 (DORADO-AC), a Phase III clinical trial evaluating darusentan, the company's endothelin receptor antagonist (ERA) for the treatment of resistant hypertension, did not achieve its co-primary efficacy endpoints of change from baseline to week 14 in trough sitting systolic blood pressure (SBP) and diastolic blood pressure (DBP) compared to placebo.
ArQule, Inc. and Daiichi Sankyo Co., Ltd. today announced the expansion of their research, development and license agreement for the discovery of novel kinase inhibitors in the field of oncology. This expanded agreement establishes a third therapeutic target, with an option for a fourth, in the field of oncology, and it includes a two-year extension based on the application of the proprietary ArQule Kinase Inhibitor Platform (AKIP™) technology.
Regenerative medicine using human pluripotent stem cells to grow transplantable tissue outside the body carries the promise to treat a range of intractable disorders, such as diabetes and Parkinson's disease.
The public has made significantly more enquiries to a national Quitline for smokers, and demand for nicotine replacement treatment vouchers has increased, following a total ban on smoking in indoor public places in New Zealand, according to a letter in this week's British Medical Journal.
Older adults living in public senior housing communities experience a large degree of loneliness, finds a new study from the Brown School at Washington University in St. Louis.
› Verified 6 days ago
Lara L Wood, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 4359 New Shepherdsville Rd, Bardstown, KY 40004 Phone: 859-278-1316 Fax: 859-276-3847 | |
Mr. Timothy M West, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 875 Pennsylvania Ave, Bardstown, KY 40004 Phone: 502-348-5685 Fax: 502-348-1771 | |
Zeth Thomas Rogers, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 1013 Granite Dr, Bardstown, KY 40004 Phone: 502-349-3100 Fax: 502-349-3169 | |
David Gerard Demar Sr., CSFA/KCSA Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 4305 New Shepherdsville Rd, Bardstown, KY 40004 Phone: 502-350-5521 | |
Hannah Johnson, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 4359 New Shepherdsville Rd Unit 245, Bardstown, KY 40004 Phone: 502-350-5492 Fax: 502-350-5822 | |
Nancy Mae Hale, P.A. Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 118 Patriot Dr, Suite 102, Bardstown, KY 40004 Phone: 502-350-1022 Fax: 502-350-1023 |